Trial watch: dendritic cell vaccination for cancer immunotherapy

J Sprooten, J Ceusters, A Coosemans… - …, 2019 - Taylor & Francis
Dendritic-cells (DCs) have received considerable attention as potential targets for the
development of anticancer vaccines. DC-based anticancer vaccination relies on patient …

Trial watch: dendritic cell vaccination for cancer immunotherapy

J Sprooten, J Ceusters, A Coosemans… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Dendritic-cells (DCs) have received considerable attention as potential targets for the
development of anticancer vaccines. DC-based anticancer vaccination relies on patient …

[引用][C] Trial watch: dendritic cell vaccination for cancer immunotherapy

J Sprooten, J Ceusters, A Coosemans, P Agostinis… - …, 2019 - cir.nii.ac.jp
Trial watch: dendritic cell vaccination for cancer immunotherapy | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Trial watch: dendritic cell vaccination for cancer immunotherapy.

J Sprooten, J Ceusters, A Coosemans… - …, 2019 - europepmc.org
Dendritic-cells (DCs) have received considerable attention as potential targets for the
development of anticancer vaccines. DC-based anticancer vaccination relies on patient …

[HTML][HTML] Trial watch: dendritic cell vaccination for cancer immunotherapy

J Sprooten, J Ceusters, A Coosemans… - …, 2019 - ncbi.nlm.nih.gov
Dendritic-cells (DCs) have received considerable attention as potential targets for the
development of anticancer vaccines. DC-based anticancer vaccination relies on patient …

[PDF][PDF] Trial watch: dendritic cell vaccination for cancer immunotherapy

J Sprooten, J Ceusters, A Coosemans, P Agostinis… - 2019 - researchgate.net
Dendritic-cells (DCs) have received considerable attention as potential targets for the
development of anticancer vaccines. DC-based anticancer vaccination relies on patient …

Trial watch: dendritic cell vaccination for cancer immunotherapy.

J Sprooten, J Ceusters, A Coosemans… - …, 2019 - europepmc.org
Dendritic-cells (DCs) have received considerable attention as potential targets for the
development of anticancer vaccines. DC-based anticancer vaccination relies on patient …